95 related articles for article (PubMed ID: 11029519)
1. Impaired Ca2+-ATPase oligomerization and increased phospholamban expression in dilated cardiomyopathy.
Lennon NJ; O'Reilly C; Ohlendieck K
Int J Mol Med; 2000 Nov; 6(5):533-8. PubMed ID: 11029519
[TBL] [Abstract][Full Text] [Related]
2. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
3. Impaired Ca2+-sequestration in dilated cardiomyopathy (review).
Lennon NJ; Ohlendieck K
Int J Mol Med; 2001 Feb; 7(2):131-41. PubMed ID: 11172615
[TBL] [Abstract][Full Text] [Related]
4. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression.
Kim HW; Ch YS; Lee HR; Park SY; Kim YH
Life Sci; 2001 Dec; 70(4):367-79. PubMed ID: 11798007
[TBL] [Abstract][Full Text] [Related]
5. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
[TBL] [Abstract][Full Text] [Related]
6. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
Minamisawa S; Hoshijima M; Chu G; Ward CA; Frank K; Gu Y; Martone ME; Wang Y; Ross J; Kranias EG; Giles WR; Chien KR
Cell; 1999 Oct; 99(3):313-22. PubMed ID: 10555147
[TBL] [Abstract][Full Text] [Related]
7. Phospholamban: a promising therapeutic target in heart failure?
Schmidt AG; Edes I; Kranias EG
Cardiovasc Drugs Ther; 2001 Sep; 15(5):387-96. PubMed ID: 11855657
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium.
Movsesian MA; Karimi M; Green K; Jones LR
Circulation; 1994 Aug; 90(2):653-7. PubMed ID: 8044934
[TBL] [Abstract][Full Text] [Related]
9. Oligomerization of the sarcoplasmic reticulum Ca2+-ATPase SERCA2 in cardiac muscle.
Lennon NJ; Harmon S; Mackey A; Ohlendieck K
Mol Cell Biol Res Commun; 1999 Jun; 1(3):182-7. PubMed ID: 10425224
[TBL] [Abstract][Full Text] [Related]
10. Improved expression and characterization of Ca2+-ATPase and phospholamban in High-Five cells.
Waggoner JR; Huffman J; Griffith BN; Jones LR; Mahaney JE
Protein Expr Purif; 2004 Mar; 34(1):56-67. PubMed ID: 14766300
[TBL] [Abstract][Full Text] [Related]
11. Phospholamban: a crucial regulator of cardiac contractility.
MacLennan DH; Kranias EG
Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
[TBL] [Abstract][Full Text] [Related]
12. Functional Co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation.
Autry JM; Jones LR
J Biol Chem; 1997 Jun; 272(25):15872-80. PubMed ID: 9188486
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the calcium ATPase with phospholamban and sarcolipin: structure, physiology and pathophysiology.
Maclennan DH
J Muscle Res Cell Motil; 2004; 25(8):600-1. PubMed ID: 16118852
[No Abstract] [Full Text] [Related]
14. Thyroid hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic reticulum by increasing Ca2+ ATPase and decreasing phospholamban expression.
Kimura Y; Otsu K; Nishida K; Kuzuya T; Tada M
J Mol Cell Cardiol; 1994 Sep; 26(9):1145-54. PubMed ID: 7815458
[TBL] [Abstract][Full Text] [Related]
15. Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.
Movsesian MA; Colyer J; Wang JH; Krall J
J Clin Invest; 1990 May; 85(5):1698-702. PubMed ID: 2139670
[TBL] [Abstract][Full Text] [Related]
16. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
[TBL] [Abstract][Full Text] [Related]
17. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
Haghighi K; Gregory KN; Kranias EG
Biochem Biophys Res Commun; 2004 Oct; 322(4):1214-22. PubMed ID: 15336969
[TBL] [Abstract][Full Text] [Related]
18. Phospholamban: a key determinant of cardiac function and dysfunction.
Rodriguez P; Kranias EG
Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
[TBL] [Abstract][Full Text] [Related]
19. Phospholamban-modulated Ca2+ transport in cardiac and slow twitch skeletal muscle sarcoplasmic reticulum.
Movsesian MA; Morris GL; Wang JH; Krall J
Second Messengers Phosphoproteins; 1992-1993; 14(3):151-61. PubMed ID: 1345340
[TBL] [Abstract][Full Text] [Related]
20. Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.
Tschöpe C; Spillmann F; Rehfeld U; Koch M; Westermann D; Altmann C; Dendorfer A; Walther T; Bader M; Paul M; Schultheiss HP; Vetter R
FASEB J; 2004 Dec; 18(15):1967-9. PubMed ID: 15448111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
